Stocks · Health care · Pharmaceutical Preparations

NEKTAR THERAPEUTICS

NKTR Clue Score14
United States Fiscal year ends December CIK 0000906709 Results filed 13 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Howard W Robin
18 Aug 2026
President & CEO
Sell
418
$71.98
$30.09K
Jonathan Zalevsky
18 Aug 2026
Chief R&D Officer
Sell
186
$71.98
$13.39K
Jonathan Zalevsky
30 Jun 2026
Chief R&D Officer
Sold on a plan
5,681
$70.00
$397.67K
Howard W Robin
17 Jun 2026
President & CEO
Sold on a plan
4,500
$61.65
$277.43K
Howard W Robin
17 Jun 2026
President & CEO
Sold on a plan
5,500
$60.81
$334.46K
Howard W Robin
16 Jun 2026
President & CEO
Sold on a plan
4,697
$60.71
$285.15K
Howard W Robin
16 Jun 2026
President & CEO
Sold on a plan
5,303
$59.97
$318.02K
Jonathan Zalevsky
15 Jun 2026
Chief R&D Officer
Sold on a plan
5,538
$60.71
$336.21K
Howard W Robin
19 May 2026
President & CEO
Sell
444
$65.51
$29.09K
Jonathan Zalevsky
19 May 2026
Chief R&D Officer
Sell
199
$65.51
$13.04K
Howard W Robin
18 Feb 2026
President & CEO
Sell
423
$73.00
$30.88K
Jonathan Zalevsky
18 Feb 2026
Chief R&D Officer
Sell
180
$73.00
$13.14K
Jonathan Zalevsky
20 Jan 2026
Chief R&D Officer
Sold on a plan
3,867
$35.67
$137.94K
Howard W Robin
25 Nov 2025
President & CEO
Sell
2,207
$54.28
$119.80K
Mark Andrew Wilson
25 Nov 2025
Chief Legal Officer
Sell
630
$54.28
$34.20K
Jonathan Zalevsky
25 Nov 2025
Chief R&D Officer
Sell
1,157
$54.28
$62.80K
Howard W Robin
9 Sep 2025
President & CEO
Sold on a plan
1,210
$48.18
$58.30K
Howard W Robin
9 Sep 2025
President & CEO
Sold on a plan
2,156
$47.49
$102.39K
Howard W Robin
9 Sep 2025
President & CEO
Sold on a plan
1,200
$46.41
$55.69K
Howard W Robin
9 Sep 2025
President & CEO
Sold on a plan
2,100
$45.16
$94.84K
Howard W Robin
5 Sep 2025
President & CEO
Sold on a plan
1,136
$39.89
$45.32K
Howard W Robin
5 Sep 2025
President & CEO
Sold on a plan
2,226
$38.82
$86.41K
Howard W Robin
5 Sep 2025
President & CEO
Sold on a plan
3,304
$37.87
$125.12K
Howard W Robin
4 Sep 2025
President & CEO
Sold on a plan
1,134
$35.80
$40.60K
Howard W Robin
4 Sep 2025
President & CEO
Sold on a plan
613
$34.40
$21.09K
Howard W Robin
4 Sep 2025
President & CEO
Sold on a plan
1,496
$33.54
$50.18K
Howard W Robin
4 Sep 2025
President & CEO
Sold on a plan
1,923
$32.37
$62.25K
Jonathan Zalevsky
4 Sep 2025
Chief R&D Officer
Sold on a plan
307
$35.69
$10.96K
Jonathan Zalevsky
4 Sep 2025
Chief R&D Officer
Sold on a plan
189
$34.41
$6.50K
Jonathan Zalevsky
4 Sep 2025
Chief R&D Officer
Sold on a plan
432
$33.60
$14.52K
Jonathan Zalevsky
4 Sep 2025
Chief R&D Officer
Sold on a plan
793
$32.43
$25.72K
Howard W Robin
2 Sep 2025
President & CEO
Sold on a plan
1,500
$30.16
$45.24K
Jonathan Zalevsky
2 Sep 2025
Chief R&D Officer
Sold on a plan
485
$30.10
$14.60K
Howard W Robin
19 Aug 2025
President & CEO
Sell
1,573
$26.59
$41.83K
Mark Andrew Wilson
19 Aug 2025
Chief Legal Officer
Sell
676
$26.59
$17.97K
Jonathan Zalevsky
19 Aug 2025
Chief R&D Officer
Sell
725
$26.59
$19.28K
Howard W Robin
19 May 2025
President & CEO
Sell
23,208
$0.67
$15.55K
Mark Andrew Wilson
19 May 2025
Chief Legal Officer
Sell
9,996
$0.67
$6.70K
Jonathan Zalevsky
19 May 2025
Chief R&D Officer
Sell
10,712
$0.67
$7.18K
Howard W Robin
19 Feb 2025
President & CEO
Sell
23,774
$1.01
$24.01K
Mark Andrew Wilson
19 Feb 2025
Chief Legal Officer
Sell
11,040
$1.01
$11.15K
Jonathan Zalevsky
19 Feb 2025
Chief R&D Officer
Sell
10,300
$1.01
$10.40K
Mark Andrew Wilson
24 Dec 2024
Chief Legal Officer
Sell
16,560
$0.89
$14.74K
Mark Andrew Wilson
23 Dec 2024
Chief Legal Officer
Sell
33,402
$0.90
$30.06K
Jonathan Zalevsky
19 Dec 2024
Chief R&D Officer
Sell
51,115
$0.94
$48.05K
Howard W Robin
18 Dec 2024
President & CEO
Sell
85,035
$0.99
$84.18K
Howard W Robin
17 Dec 2024
President & CEO
Sell
46,995
$1.01
$47.46K
Howard W Robin
19 Nov 2024
President & CEO
Sell
16,278
$1.01
$16.44K
Mark Andrew Wilson
19 Nov 2024
Chief Legal Officer
Sell
6,407
$1.01
$6.47K
Jonathan Zalevsky
19 Nov 2024
Chief R&D Officer
Sell
7,785
$1.01
$7.86K
Howard W Robin
19 Aug 2024
President & CEO
Sell
14,881
$1.28
$19.05K
Mark Andrew Wilson
19 Aug 2024
Chief Legal Officer
Sell
5,651
$1.28
$7.23K
Jonathan Zalevsky
19 Aug 2024
Chief R&D Officer
Sell
6,866
$1.28
$8.79K
Robert Chess
14 Jun 2024
Director
Sold on a plan
19,500
$1.20
$23.40K
Mark Andrew Wilson
17 May 2024
Chief Legal Officer
Sell
6,260
$1.75
$10.96K
Jonathan Zalevsky
17 May 2024
Chief R&D Officer
Sell
7,355
$1.75
$12.87K
Howard W Robin
17 May 2024
President & CEO
Sell
16,650
$1.75
$29.14K
Deep Track Capital, LP
10 May 2024
10% owner
Sell indirect
56,000
$1.78
$99.63K
Howard W Robin
20 Feb 2024
President & CEO
Sell
20,033
$0.68
$13.62K
Mark Andrew Wilson
20 Feb 2024
Chief Legal Officer
Sell
7,606
$0.68
$5.17K
Jonathan Zalevsky
20 Feb 2024
Chief R&D Officer
Sell
9,014
$0.68
$6.13K
Howard W Robin
17 Nov 2023
President & CEO
Sell
19,877
$0.49
$9.74K
Mark Andrew Wilson
17 Nov 2023
Chief Legal Officer
Sell
7,179
$0.49
$3.52K
Jonathan Zalevsky
17 Nov 2023
Chief R&D Officer
Sell
9,646
$0.49
$4.73K
Jeffrey Robert Ajer
18 Sep 2023
Director
Sell
4,359
$0.69
$3.01K
Myriam Curet
18 Sep 2023
Director
Sell
4,359
$0.69
$3.01K
Howard W Robin
16 Aug 2023
President & CEO
Sell
19,998
$0.78
$15.60K
Mark Andrew Wilson
16 Aug 2023
Chief Legal Officer
Sell
7,221
$0.78
$5.63K
Jonathan Zalevsky
16 Aug 2023
Chief R&D Officer
Sell
9,703
$0.78
$7.57K
Roy A Whitfield
14 Jun 2023
Director
Sold on a plan
30,000
$0.57
$17.10K
Howard W Robin
16 May 2023
President & CEO
Sell
20,361
$0.72
$14.66K
Mark Andrew Wilson
16 May 2023
Chief Legal Officer
Sell
7,543
$0.72
$5.43K
Jonathan Zalevsky
16 May 2023
Chief R&D Officer
Sell
9,791
$0.72
$7.05K
Howard W Robin
16 Feb 2023
President & CEO
Sell
19,635
$3.00
$58.91K
Jillian B. Thomsen
16 Feb 2023
Chief Financial Officer
Sell
10,267
$3.00
$30.80K
Mark Andrew Wilson
16 Feb 2023
Chief Legal Officer
Sell
8,275
$3.00
$24.83K
Jonathan Zalevsky
16 Feb 2023
Chief R&D Officer
Sell
10,484
$3.00
$31.45K
Mark Andrew Wilson
16 Nov 2022
Chief Legal Officer
Sell
8,690
$3.57
$31.02K
Howard W Robin
16 Nov 2022
President & CEO
Sell
38,014
$3.57
$135.71K
Jillian B. Thomsen
16 Nov 2022
Chief Financial Officer
Sell
11,095
$3.57
$39.61K
Jonathan Zalevsky
16 Nov 2022
Chief R&D Officer
Sell
13,460
$3.57
$48.05K
Jeffrey Robert Ajer
23 Sep 2022
Director
Sell
4,198
$3.16
$13.27K
Myriam Curet
23 Sep 2022
Director
Sell
4,198
$3.16
$13.27K
Robert Chess
22 Sep 2022
Director
Sell
5,100
$3.19
$16.27K
Robert Chess
22 Sep 2022
Director
Sold on a plan
10,200
$0.67
$6.83K
Karin Eastham
13 Sep 2022
Director
Sell
21,267
$3.61
$76.77K
Jonathan Zalevsky
18 Aug 2022
Chief R&D Officer
Sell
73,716
$4.65
$342.78K
Howard W Robin
16 Aug 2022
President & CEO
Sell
13,759
$4.76
$65.49K
Jillian B. Thomsen
16 Aug 2022
SVP & Chief Accounting Officer
Sell
2,006
$4.76
$9.55K
Mark Andrew Wilson
16 Aug 2022
SVP & General Counsel
Sell
3,189
$4.76
$15.18K
Jonathan Zalevsky
16 Aug 2022
Chief R&D Officer
Sell
10,560
$4.76
$50.27K
Gil M Labrucherie
16 May 2022
SVP, COO & CFO
Sell
17,448
$3.95
$68.92K
John Northcott
16 May 2022
SVP & Chief Commercial Officer
Sell
4,592
$3.95
$18.14K
Howard W Robin
16 May 2022
President & CEO
Sell
36,529
$3.95
$144.29K
Jillian B. Thomsen
16 May 2022
SVP & Chief Accounting Officer
Sell
5,841
$3.95
$23.07K
Mark Andrew Wilson
16 May 2022
SVP & General Counsel
Sell
3,136
$3.95
$12.39K
Jonathan Zalevsky
16 May 2022
Chief R&D Officer
Sell
21,673
$3.95
$85.61K
Gil M Labrucherie
16 Feb 2022
SVP, COO & CFO
Sell
7,579
$10.95
$82.99K
John Northcott
16 Feb 2022
SVP & Chief Commercial Officer
Sell
4,852
$10.95
$53.13K
Howard W Robin
16 Feb 2022
President & CEO
Sell
12,480
$10.95
$136.66K
Jillian B. Thomsen
16 Feb 2022
SVP & Chief Accounting Officer
Sell
2,363
$10.95
$25.87K
Mark Andrew Wilson
16 Feb 2022
SVP & General Counsel
Sell
3,661
$10.95
$40.09K
Jonathan Zalevsky
16 Feb 2022
Chief R&D Officer
Sell
10,912
$10.95
$119.49K
Gil M Labrucherie
18 Nov 2021
SVP, COO & CFO
Sell
3,000
$12.69
$38.07K
John Northcott
16 Nov 2021
SVP & Chief Commercial Officer
Sell
6,061
$13.16
$79.76K
Howard W Robin
16 Nov 2021
President & CEO
Sell
42,773
$13.16
$562.89K
Jillian B. Thomsen
16 Nov 2021
SVP & Chief Accounting Officer
Sell
6,741
$13.16
$88.71K
Mark Andrew Wilson
16 Nov 2021
SVP & General Counsel
Sell
6,564
$13.16
$86.38K
Jonathan Zalevsky
16 Nov 2021
Chief R&D Officer
Sell
20,869
$13.16
$274.64K
Gil M Labrucherie
16 Nov 2021
SVP, COO & CFO
Sell
21,149
$13.16
$278.32K
R Scott Greer
9 Nov 2021
Director
Exercised, kept
12,500
$12.80
$160.00K
Jeffrey Robert Ajer
22 Sep 2021
Director
Sell
3,665
$17.78
$65.16K
Robert Chess
22 Sep 2021
Director
Sell
4,600
$17.94
$82.52K
Myriam Curet
22 Sep 2021
Director
Sell
3,665
$17.78
$65.16K
Roy A Whitfield
16 Sep 2021
Director
Exercised, kept
40,000
$13.80
$552.00K
Robert Chess
9 Sep 2021
Director
Sold after exercise
10,279
$16.02
$164.67K
Robert Chess
8 Sep 2021
Director
Sold after exercise
8,000
$16.00
$128.00K
R Scott Greer
31 Aug 2021
Director
Exercised, kept
45,000
$12.70
$571.50K
Gil M Labrucherie
17 Aug 2021
SVP, COO & CFO
Sell
3,000
$13.56
$40.68K
Gil M Labrucherie
16 Aug 2021
SVP, COO & CFO
Sell
7,867
$13.83
$108.80K
John Northcott
16 Aug 2021
SVP & Chief Commercial Officer
Sell
6,192
$13.83
$85.64K
Jillian B. Thomsen
16 Aug 2021
SVP & Chief Accounting Officer
Sell
13,339
$13.83
$184.48K
Howard W Robin
16 Aug 2021
President & CEO
Sell
11,515
$13.83
$159.25K
Mark Andrew Wilson
16 Aug 2021
SVP & General Counsel
Sell
1,910
$13.83
$26.42K
Jonathan Zalevsky
16 Aug 2021
Chief R&D Officer
Sell
7,662
$13.83
$105.97K
Robert Chess
22 Jul 2021
Director
Sold after exercise
91
$16.80
$1.53K
Robert Chess
21 Jul 2021
Director
Sold after exercise
3,524
$16.81
$59.24K
Robert Chess
20 Jul 2021
Director
Sold after exercise
2,106
$16.80
$35.38K
Gil M Labrucherie
17 May 2021
SVP, COO & CFO
Sell
7,898
$18.30
$144.53K
John Northcott
17 May 2021
SVP & Chief Commercial Officer
Sell
6,085
$18.30
$111.36K
Howard W Robin
17 May 2021
President & CEO
Sell
11,560
$18.30
$211.55K
Jillian B. Thomsen
17 May 2021
SVP & Chief Accounting Officer
Sell
13,391
$18.30
$245.06K
Mark Andrew Wilson
17 May 2021
SVP & General Counsel
Sell
1,917
$18.30
$35.08K
Jonathan Zalevsky
17 May 2021
Chief R&D Officer
Sell
31,111
$18.30
$569.33K
Robert Chess
12 May 2021
Director
Sold after exercise
8,000
$19.34
$154.72K
Robert Chess
14 Apr 2021
Director
Sold after exercise
8,000
$18.98
$151.84K
Gil M Labrucherie
16 Feb 2021
SVP, COO & CFO
Sell
7,977
$22.37
$178.45K
John Northcott
16 Feb 2021
SVP & Chief Commercial Officer
Sell
15,358
$22.37
$343.56K
Howard W Robin
16 Feb 2021
President & CEO
Sell
11,495
$22.37
$257.14K
Jillian B. Thomsen
16 Feb 2021
SVP & Chief Accounting Officer
Sell
11,705
$22.37
$261.84K
Mark Andrew Wilson
16 Feb 2021
SVP & General Counsel
Sell
2,173
$22.37
$48.61K
Jonathan Zalevsky
16 Feb 2021
Chief R&D Officer
Sell
24,141
$22.37
$540.03K
Gil M Labrucherie
4 Feb 2021
SVP, COO & CFO
Sold after exercise
50,000
$19.81
$990.50K
Howard W Robin
4 Feb 2021
President & CEO
Sold after exercise
58,137
$20.58
$1.20M
Howard W Robin
4 Feb 2021
President & CEO
Sold after exercise
91,863
$20.10
$1.85M
Gil M Labrucherie
3 Feb 2021
SVP, COO & CFO
Sold after exercise
50,000
$19.61
$980.50K
Howard W Robin
3 Feb 2021
President & CEO
Sold after exercise
150,000
$19.72
$2.96M
Mark Andrew Wilson
3 Feb 2021
SVP & General Counsel
Sold after exercise
5,344
$19.45
$103.94K
Gil M Labrucherie
2 Feb 2021
SVP, COO & CFO
Sold after exercise
1,933
$21.66
$41.87K
Gil M Labrucherie
2 Feb 2021
SVP, COO & CFO
Sold after exercise
6,932
$20.96
$145.29K
Gil M Labrucherie
2 Feb 2021
SVP, COO & CFO
Sold after exercise
41,135
$19.97
$821.47K
Howard W Robin
2 Feb 2021
President & CEO
Sold after exercise
600
$21.59
$12.95K
Howard W Robin
2 Feb 2021
President & CEO
Sold after exercise
9,900
$20.84
$206.32K
Howard W Robin
2 Feb 2021
President & CEO
Sold after exercise
139,500
$19.69
$2.75M
Jillian B. Thomsen
28 Jan 2021
SVP & Chief Accounting Officer
Sold after exercise
75,000
$18.62
$1.40M
R Scott Greer
5 Jan 2021
Director
Exercised, kept
40,000
$13.80
$552.00K
Myriam Curet
15 Dec 2020
Director
Sell
1,560
$17.82
$27.80K
Jonathan Zalevsky
23 Nov 2020
Chief R&D Officer
Sell
16,380
$16.40
$268.63K
Gil M Labrucherie
16 Nov 2020
SVP, COO & CFO
Sell
8,276
$16.93
$140.11K
Howard W Robin
16 Nov 2020
President & CEO
Sell
11,975
$16.93
$202.74K
Jillian B. Thomsen
16 Nov 2020
SVP & Chief Accounting Officer
Sell
11,976
$16.93
$202.75K
Mark Andrew Wilson
16 Nov 2020
SVP & General Counsel
Sell
1,539
$16.93
$26.06K
Jonathan Zalevsky
16 Nov 2020
Chief R&D Officer
Sell
29,618
$16.93
$501.43K
Jeffrey Robert Ajer
28 Sep 2020
Director
Sell
3,250
$17.25
$56.06K
Robert Chess
25 Sep 2020
Director
Sell
5,500
$17.75
$97.63K
Jeffrey Robert Ajer
21 Sep 2020
Director
Sell
2,250
$19.74
$44.42K
Gil M Labrucherie
17 Sep 2020
SVP, COO & CFO
Sell
2,000
$19.96
$39.92K
Robert Chess
8 Sep 2020
Director
Sold after exercise
8,000
$18.53
$148.24K
Roy A Whitfield
4 Sep 2020
Director
Exercised, kept
30,000
$9.24
$277.20K
Gil M Labrucherie
18 Aug 2020
SVP, COO & CFO
Sell
2,000
$19.68
$39.36K
Gil M Labrucherie
17 Aug 2020
SVP, COO & CFO
Sell
6,245
$19.67
$122.84K
Howard W Robin
17 Aug 2020
President & CEO
Sell
11,885
$19.67
$233.78K
Jillian B. Thomsen
17 Aug 2020
SVP & Chief Accounting Officer
Sell
1,367
$19.67
$26.89K
Mark Andrew Wilson
17 Aug 2020
SVP & General Counsel
Sell
1,529
$19.67
$30.08K
Jonathan Zalevsky
17 Aug 2020
Chief R&D Officer
Sell
26,200
$19.67
$515.35K
R Scott Greer
9 Jul 2020
Director
Sold after exercise
15,009
$25.00
$375.23K
Robert Chess
8 Jul 2020
Director
Sold after exercise
8,000
$24.58
$196.64K
Gil M Labrucherie
19 May 2020
SVP, COO & CFO
Sell
2,000
$22.62
$45.24K
Gil M Labrucherie
18 May 2020
SVP, COO & CFO
Sell
5,727
$22.51
$128.91K
Howard W Robin
18 May 2020
President & CEO
Sell
8,968
$22.51
$201.87K
Jillian B. Thomsen
18 May 2020
SVP & Chief Accounting Officer
Sell
1,367
$22.51
$30.77K
Mark Andrew Wilson
18 May 2020
SVP & General Counsel
Sell
1,529
$22.51
$34.42K
Jonathan Zalevsky
18 May 2020
Chief R&D Officer
Sell
4,558
$22.51
$102.60K
Robert Chess
15 Apr 2020
Director
Sold after exercise
197
$19.02
$3.75K
Robert Chess
15 Apr 2020
Director
Sold after exercise
7,803
$18.36
$143.26K
Robert Chess
11 Mar 2020
Director
Sold after exercise
1,200
$17.41
$20.89K
Robert Chess
11 Mar 2020
Director
Sold after exercise
6,800
$16.68
$113.42K
Gil M Labrucherie
18 Feb 2020
SVP, COO & CFO
Sell
5,938
$22.35
$132.71K
Howard W Robin
18 Feb 2020
President & CEO
Sell
8,448
$22.35
$188.81K
Jillian B. Thomsen
18 Feb 2020
SVP & Chief Accounting Officer
Sell
1,394
$22.35
$31.16K
Jonathan Zalevsky
18 Feb 2020
Chief R&D Officer
Sell
4,774
$22.35
$106.70K
Robert Chess
12 Feb 2020
Director
Sold after exercise
3,599
$23.72
$85.37K
Robert Chess
12 Feb 2020
Director
Sold after exercise
4,401
$23.32
$102.63K
Jillian B. Thomsen
6 Feb 2020
SVP & Chief Accounting Officer
Sold after exercise
37,500
$22.78
$854.25K
Roy A Whitfield
18 Dec 2019
Director
Exercised, kept
10,000
$9.24
$92.40K
Gil M Labrucherie
18 Nov 2019
SVP, COO & CFO
Sell
8,863
$17.97
$159.27K
Howard W Robin
18 Nov 2019
President & CEO
Sell
13,556
$17.97
$243.60K
Jillian B. Thomsen
18 Nov 2019
SVP & Chief Accounting Officer
Sell
2,713
$17.97
$48.75K
Jonathan Zalevsky
18 Nov 2019
Chief R&D Officer
Sell
3,960
$17.97
$71.16K
Gil M Labrucherie
13 Nov 2019
SVP, COO & CFO
Sold after exercise
25,000
$19.79
$494.75K
Howard W Robin
17 Oct 2019
President & CEO
Sold after exercise
33,333
$17.68
$589.33K
Howard W Robin
16 Oct 2019
President & CEO
Sold after exercise
33,334
$17.48
$582.68K
Gil M Labrucherie
15 Oct 2019
SVP, COO & CFO
Sold after exercise
25,000
$15.83
$395.75K
Howard W Robin
15 Oct 2019
President & CEO
Sold after exercise
24,500
$17.17
$420.67K
Howard W Robin
15 Oct 2019
President & CEO
Sold after exercise
8,833
$16.35
$144.42K
Jeffrey Robert Ajer
30 Sep 2019
Director
Sell
2,375
$18.06
$42.89K
Robert Chess
27 Sep 2019
Director
Sell
4,000
$17.99
$71.96K
Lutz Lingnau
27 Sep 2019
Director
Sell
3,000
$17.84
$53.52K
Jeffrey Robert Ajer
20 Sep 2019
Director
Sell
2,250
$20.24
$45.54K
Gil M Labrucherie
16 Sep 2019
SVP & Chief Financial Officer
Sold after exercise
25,000
$20.52
$513.00K
Stephen K Doberstein
5 Sep 2019
SVP & Chief Scientific Officer
Buy
15,000
$17.28
$259.20K
Gil M Labrucherie
26 Aug 2019
SVP & Chief Financial Officer
Exercised, kept
30,000
$16.31
$489.30K
Howard W Robin
23 Aug 2019
President & CEO
Exercised, kept
30,000
$16.31
$489.30K
Stephen K Doberstein
16 Aug 2019
SVP & Chief Scientific Officer
Sell
3,245
$18.15
$58.90K
Gil M Labrucherie
16 Aug 2019
SVP & Chief Financial Officer
Sell
5,063
$18.15
$91.89K
John Nicholson
16 Aug 2019
SVP & Chief Operating Officer
Sell
3,819
$18.15
$69.31K
Howard W Robin
16 Aug 2019
President & CEO
Sell
12,551
$18.15
$227.80K
Jillian B. Thomsen
16 Aug 2019
SVP & Chief Accounting Officer
Sell
1,809
$18.15
$32.83K
Gil M Labrucherie
14 Aug 2019
SVP & Chief Financial Officer
Sold after exercise
25,000
$17.79
$444.75K
Howard W Robin
25 Jul 2019
President & CEO
Sold after exercise
33,333
$29.65
$988.32K
Howard W Robin
24 Jul 2019
President & CEO
Sold after exercise
33,334
$32.11
$1.07M
Howard W Robin
23 Jul 2019
President & CEO
Sold after exercise
33,333
$32.10
$1.07M
Gil M Labrucherie
10 Jul 2019
SVP & Chief Financial Officer
Sold after exercise
25,000
$34.57
$864.25K
Lutz Lingnau
8 Jul 2019
Director
Sold after exercise
10,000
$34.63
$346.30K
Gil M Labrucherie
17 Jun 2019
SVP & Chief Financial Officer
Sold after exercise
25,000
$33.71
$842.75K
Howard W Robin
23 May 2019
President & CEO
Sold after exercise
33,333
$32.69
$1.09M
Howard W Robin
22 May 2019
President & CEO
Sold after exercise
33,334
$33.38
$1.11M
Howard W Robin
21 May 2019
President & CEO
Sold after exercise
33,333
$32.93
$1.10M
Stephen K Doberstein
16 May 2019
SVP & Chief Scientific Officer
Sell
3,461
$31.37
$108.57K
Maninder Hora
16 May 2019
SVP Pharma Dev & Mfg Ops
Sell
2,449
$31.37
$76.83K
Gil M Labrucherie
16 May 2019
SVP & Chief Financial Officer
Sell
3,767
$31.37
$118.17K
John Nicholson
16 May 2019
SVP & Chief Operating Officer
Sell
4,077
$31.37
$127.90K
Howard W Robin
16 May 2019
President & CEO
Sell
13,383
$31.37
$419.82K
Jillian B. Thomsen
16 May 2019
SVP & Chief Accounting Officer
Sell
1,928
$31.37
$60.48K
R Scott Greer
8 Mar 2019
Director
Exercised, kept
10,000
$5.14
$51.40K
Howard W Robin
21 Feb 2019
President & CEO
Sold after exercise
33,333
$41.01
$1.37M
Howard W Robin
20 Feb 2019
President & CEO
Sold after exercise
33,334
$43.20
$1.44M
Stephen K Doberstein
19 Feb 2019
SVP & Chief Scientific Officer
Sell
3,310
$42.39
$140.31K
Maninder Hora
19 Feb 2019
SVP Pharma Dev & Mfg Ops
Sell
2,386
$42.39
$101.14K
Gil M Labrucherie
19 Feb 2019
SVP & Chief Financial Officer
Sell
3,592
$42.39
$152.26K
John Nicholson
19 Feb 2019
SVP & Chief Operating Officer
Sell
3,822
$42.39
$162.01K
Howard W Robin
19 Feb 2019
President & CEO
Sold after exercise
8,882
$42.39
$376.51K
Howard W Robin
19 Feb 2019
President & CEO
Sold after exercise
33,333
$42.32
$1.41M
Jillian B. Thomsen
19 Feb 2019
SVP & Chief Accounting Officer
Sell
1,808
$42.39
$76.64K
Jillian B. Thomsen
4 Feb 2019
SVP & Chief Accounting Officer
Sold after exercise
16,119
$42.16
$679.58K
John Nicholson
28 Jan 2019
SVP & Chief Operating Officer
Sold after exercise
63,000
$42.82
$2.70M
Stephen K Doberstein
16 Nov 2018
SVP & Chief Scientific Officer
Sell
4,524
$38.25
$173.04K
Maninder Hora
16 Nov 2018
SVP Pharma Dev & Mfg Ops
Sell
4,694
$38.25
$179.55K
Gil M Labrucherie
16 Nov 2018
SVP & Chief Financial Officer
Sell
6,515
$38.25
$249.20K
John Nicholson
16 Nov 2018
SVP & Chief Operating Officer
Sell
5,982
$38.25
$228.81K
Showing 250 of 382 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 431
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 122
Sales at will 212
Transactions with no price 0
Shares from compensation/vesting 10,057,054
Sales filed before the plan box existed 165
History held since 7 Nov 2006